University of Rochester

This user is yet to add a description about themselves

User Verified

Get Started

Innovations

Gpr177 as a Drug Target for Cancer Treatment

Inhibition of Gpr177 poses a therapeutic solution for disorders caused by aberrant Wnt signaling cascade, such as cancer. We would like to partner with AbbVie to advance this technology and ultimately identify therapeutic molecules to inhibit Gpr177 and treat cancers.

By Rutgers University

Published

Healthcare & Pharmaceuticals

Skin cream for dermatitis

Our technology related to a promising topical cream that can be used to manage dermatitis, including contact and allergic contact dermatitis and atopic dermatitis.

By University of Rochester

University of Rochester

Connection Limit

You’ve reached your connections limit

Gpr177 as a Drug Target for Cancer Treatment

Skin cream for dermatitis